JournalTOCs

Followed Journals

Journal you Follow: 0

Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Jurnals are published.
Already have an account? Sign In to see the journals you follow.

Most Followed Journals

Top Publishers

Top Subjects

The Medical Letter

Subscription journal
ISSN (Print) 0025-732X - ISSN (Online) 1523-2859
Published by The Medical Letter, Inc

[1 journal]

Canagliflozin (Invokana) for Type 2 Diabetes - The Medical Letter
- Authors: admin
  Abstract: May 13, 2013 - Canagliflozin (kan" a gli floe' zin; Invokana – Janssen), a sodium-glucose co-transporter 2 (SGLT2) inhibitor, has been approved by the FDA for oral treatment of type 2 diabetes.
Pasireotide (Signifor) for Cushing's Disease - The Medical Letter
- Authors: admin
  Abstract: May 13, 2013 - The FDA has approved the somatostatin analog pasireotide diaspartate (Signifor – Novartis) for treatment of adults with Cushing's disease (cortisol excess caused by an ACTH-secreting pituitary tumor) who are not candidates for pituitary surgery or for whom surgery has not been curative. Pasireotide is the first drug approved in the US specifically to treat Cushing's disease. The antiprogestin mifepristone (Korlym) was approved last year for control of hyperglycemia in patients with Cushing's syndrome, which includes other causes of hypercortisolism, such as exogenous steroids and carcinomas that produce cortisol independently of ACTH.
Drugs for Allergic Disorders - Treatment Guidelines
- Authors: admin
  Abstract: May 1, 2013 - The use of drugs to prevent and control symptoms of allergic disorders can be optimized when patients avoid exposure to specific allergens and/or environmental conditions that trigger or worsen their symptoms.